Skip to content

Burden and sequelae of influenza and SARSCoV-2 among adults a multisite study in India

Burden and sequelae of influenza, SARSCo-V2 and other respiratory viruses associated Severe Acute Respiratory Infections among adult Indian Population aged 18-60 years

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/052797
Enrollment
20000
Registered
2023-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: U071- COVID 19 virus identified Health Condition 2: J09-J18- Influenza and pneumonia Health Condition 3: J20-J22- Other acute lower respiratory infections

Interventions

None listed

Sponsors

AIIMS , NEW DELHI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Admitted patients screened within 24 hours of admission Onset of fever (>= 38 C°) and cough within last 10 days of admission Willing to give consent for storage of blood samples and telephonic/physical follow up

Exclusion criteria

Exclusion criteria: Cases who have been admitted for more than 48 hours for the current episode at the time of screening will be excluded to avoid SARI cases due to hospital acquired infection

Design outcomes

Primary

MeasureTime frame
1.Influenza and SARS Co-V positivity among adult SARI admission in tertiary and secondary hospital; 2. Incidence of SARI in rural and urban community and its health care seeking 3. Percentage of patients with diagnostic investigations and treatment options 4. Mean total cost of treatment of SARI/INFLUENZA / COVID admissions 5. Cumulative incidence of sequelae in subjects hospitalized with influenza or SARScov2 6. Incidence of influenza and SARSCoV2 infection among healthcare workers 7.Vaccination use hesitancy among healthcare workers and its determinantsTimepoint: Continuous data collection

Secondary

MeasureTime frame
1. Proportions of enrolled SARI patients with different outcomes i.e. death or, ICU admission or, discharge and their predictors 2. Identification of risk factors for development of specific sequelae & re-infection 3. QoL of Patients with sequelae 4. Absenteeism due to respiratory infections in HCWTimepoint: Continuous data collection

Countries

India

Contacts

Public ContactAnand Krishnan

ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI

anand.drk@gmail.com01126594253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026